MARKER THERAPEUTICS, INC. Gains (Losses) on Restructuring of Debt
MARKER THERAPEUTICS, INC. (MRKR) reported Gains (Losses) on Restructuring of Debt of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnRestructuringOfDebt · last filed 2018-03-23
- MARKER THERAPEUTICS, INC. gains (losses) on restructuring of debt for the quarter ending 2017-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. gains (losses) on restructuring of debt for the quarter ending 2017-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. gains (losses) on restructuring of debt for the quarter ending 2017-06-30 was $0.00.
- MARKER THERAPEUTICS, INC. gains (losses) on restructuring of debt for the quarter ending 2017-03-31 was $0.00.
- MARKER THERAPEUTICS, INC. gains (losses) on restructuring of debt for fiscal 2017 was $0.00.
- MARKER THERAPEUTICS, INC. gains (losses) on restructuring of debt for fiscal 2016 was -$135.64K.
- MARKER THERAPEUTICS, INC. gains (losses) on restructuring of debt for fiscal 2012 was -$104.55K.
- MARKER THERAPEUTICS, INC. gains (losses) on restructuring of debt for fiscal 2010 was -$1.52M.
| Period end | Gains (Losses) on Restructuring of Debt 3 month | Gains (Losses) on Restructuring of Debt 6 month | Gains (Losses) on Restructuring of Debt 6 month as first filed | Gains (Losses) on Restructuring of Debt 9 month | Gains (Losses) on Restructuring of Debt 9 month as first filed | Gains (Losses) on Restructuring of Debt 12 month | Gains (Losses) on Restructuring of Debt 143 month | Gains (Losses) on Restructuring of Debt 146 month | Gains (Losses) on Restructuring of Debt 149 month | Gains (Losses) on Restructuring of Debt 152 month | Gains (Losses) on Restructuring of Debt 155 month | Gains (Losses) on Restructuring of Debt 158 month | Gains (Losses) on Restructuring of Debt 161 month | Gains (Losses) on Restructuring of Debt 164 month | Gains (Losses) on Restructuring of Debt 167 month | Gains (Losses) on Restructuring of Debt 170 month | Gains (Losses) on Restructuring of Debt 173 month | Gains (Losses) on Restructuring of Debt 179 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $0.00 derived: sum of 2 quarters · filed 2018-03-23 | $0.00 derived: sum of 3 quarters · filed 2018-03-23 | $0.00 10-K · filed 2018-03-23 | ||||||||||||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 4 quarters · filed 2018-03-23 | ||||||||||||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-07 | $0.00 10-Q · filed 2017-08-07 | $0.00 derived: sum of 3 quarters · filed 2018-03-23 | -$65.33K derived: sum of 4 quarters · filed 2018-03-23 | ||||||||||||||
| 2017-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2018-03-23 | $0.00 derived: sum of 2 quarters · filed 2018-03-23 | -$65.33K derived: sum of 3 quarters · filed 2018-03-23 | -$135.64K derived: sum of 4 quarters · filed 2018-03-23 | ||||||||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | -$65.33K derived: sum of 2 quarters · filed 2018-03-23 | -$135.64K derived: sum of 3 quarters · filed 2018-03-23 | -$135.64K 10-K · filed 2018-03-23 | ||||||||||||||
| 2016-09-30 | -$65.33K 10-Q · filed 2017-11-14 | -$135.64K derived: sum of 2 quarters · filed 2017-11-14 | -$135.64K 10-Q · filed 2017-11-14 | |||||||||||||||
| 2016-06-30 | -$70.31K 10-Q · filed 2017-08-07 | -$70.31K 10-Q · filed 2017-08-07 | ||||||||||||||||
| 2014-06-30 | $1.37M 10-Q · filed 2014-08-18 | |||||||||||||||||
| 2013-12-31 | -$1.37M 10-Q/A · filed 2014-05-21 | |||||||||||||||||
| 2013-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | $200.00K 10-Q · filed 2014-11-19 | -$200.00K 10-Q · filed 2013-11-19 | -$1.57M 10-Q · filed 2013-11-19 | ||||||||||||||
| 2013-06-30 | $96.00K 10-Q · filed 2014-08-18 | -$96.00K 10-Q · filed 2013-08-19 | -$1.47M 10-Q · filed 2013-08-19 | |||||||||||||||
| 2013-03-31 | -$1.37M 10-Q/A · filed 2013-08-19 | |||||||||||||||||
| 2012-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | -$104.55K derived: sum of 2 quarters · filed 2013-05-15 | -$104.55K derived: sum of 3 quarters · filed 2013-05-15 | -$104.55K 10-K/A · filed 2014-04-17 | -$1.37M 10-K · filed 2013-05-15 | |||||||||||||
| 2012-09-30 | -$85.55K 10-Q · filed 2012-11-19 | -$85.55K derived: sum of 2 quarters · filed 2012-11-19 | -$85.55K 10-Q · filed 2013-11-19 | -$1.35M 10-Q · filed 2012-11-19 | ||||||||||||||
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-12 | $0.00 10-Q/A · filed 2012-09-12 | -$1.27M 10-Q/A · filed 2012-09-12 | |||||||||||||||
| 2012-03-31 | -$1.27M 10-Q · filed 2012-05-21 | |||||||||||||||||
| 2011-12-31 | -$1.27M 10-K · filed 2012-04-16 | |||||||||||||||||
| 2011-09-30 | -$1.64M 10-Q · filed 2011-11-21 | |||||||||||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-12 | $0.00 10-Q/A · filed 2012-09-12 | -$1.64M 10-Q · filed 2011-08-22 | |||||||||||||||
| 2010-12-31 | $96.25K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $96.25K derived: sum of 2 quarters · filed 2012-04-16 | -$1.52M derived: sum of 3 quarters · filed 2012-04-16 | -$1.52M 10-K · filed 2012-04-16 | ||||||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | -$1.62M derived: sum of 2 quarters · filed 2011-11-21 | -$1.62M 10-Q · filed 2011-11-21 | |||||||||||||||
| 2010-06-30 | -$1.62M 10-Q · filed 2011-08-22 | -$1.62M 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |